Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer – Gerhardt Attard
Alicia Morgans interviews Gerhardt Attard about groundbreaking research presented at ESMO 2023, utilizing the STAMPEDE data s [...]
Dr. Parker and Dr. Attard on the utility of ArteraAI in metastatic prostate cancer
In this video, Charles Parker, MD, and Gerhardt Attard, MD, PhD, discuss notable findings from the study “External validation [...]
VIDEO: ‘Practice-changing’ AI-derived biomarker can tailor ADT in high-risk prostate cancer
In this Healio video exclusive, Andrew Armstrong, MD, discusses his presentation from the Genitourinary Cancer session at the [...]
The Artera AI Model: Advancing Personalized Medicine in Prostate Cancer Treatment | Dan Spratt & Alicia Morgans Discuss NEJM Evidence Manuscript
Dan Spratt joins Alicia Morgans in a conversation on the Artera AI multimodal artificial intelligence model manuscript publis [...]
Personalizing Prostate Cancer Therapy Using AI-based Predictive Biomarkers – Paul Nguyen
In a discussion with Alicia Morgans, Paul Nguyen highlights the advancing role of predictive biomarkers in prostate cancer tr [...]
Artera Multi-Modal AI Platform – Guiding Treatment Decisions in Men with Prostate Cancer – Andre Esteva & Felix Feng
Andre Esteva and Felix Feng join Alicia Morgans to discuss the Artera MMAI platform in prostate cancer intended to identify p [...]
Beyond the NCCN Localized Prostate Cancer Risk Category: The MMAI Prognostic Risk Stratification Model – Jonathan Tward
Jonathan Tward joins Alicia Morgans to discuss advancing prognostic capabilities in prostate cancer risk stratification using [...]
Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate Cancer – Daniel Spratt
Alicia Morgans and Daniel Spratt discuss an AI-derived multi-modal digital pathology-based biomarker test designed towards im [...]
Dr. Spratt Highlights the Validation of an MMAI Prognostic Biomarker for Prostate Cancer
Urology Times features a video of Daniel Spratt, MD discussing results demonstrating successful validation of ArteraAI’s MMAI [...]